Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
1.350
0.00 (0.00%)
At close: Jul 2, 2024, 3:59 PM
1.320
-0.030 (-2.22%)
After-hours: Jul 2, 2024, 7:49 PM EDT
Milestone Pharmaceuticals Stock Forecast
MIST's stock price has decreased by -59.7% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MIST stock have an average target of 15, with a low estimate of 5.00 and a high estimate of 25. The average target predicts an increase of 1,011.11% from the current stock price of 1.35.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for MIST stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 2 | 2 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 4 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,751.85% | May 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,751.85% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,751.85% | Mar 22, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +270.37% | Mar 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,751.85% | Feb 26, 2024 |
Financial Forecast
Revenue This Year
n/a
from 1.00M
Revenue Next Year
5.64M
EPS This Year
-0.81
from -1.39
EPS Next Year
-1.25
from -0.81
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 11.3M | 54.2M | 178.7M | 301.0M |
Avg | n/a | 5.6M | 30.6M | 116.6M | 230.9M |
Low | n/a | 1.8M | 8.2M | 57.3M | 162.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 860.0% | 484.0% | 158.1% |
Avg | - | - | 442.2% | 281.2% | 98.0% |
Low | - | - | 45.9% | 87.4% | 39.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.62 | -0.74 | -0.47 | 0.08 | 2.15 |
Avg | -0.81 | -1.25 | -0.65 | 0.08 | 2.09 |
Low | -0.92 | -1.84 | -0.81 | 0.08 | 2.01 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 2,537.9% |
Avg | - | - | - | - | 2,462.5% |
Low | - | - | - | - | 2,362.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.